CSF2 and hepatocellular carcinoma: Notably, the DCs in HCC immunotherapies that we discussed above were mainly obtained by adding GM-CSF and IL-4 to PBMCs or mouse bone marrow cells in culture, which are also known as MoDCs (monocyte-derived dendritic cells) or BMDCs [114].